Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement

Neutral lipid storage disease with myopathy (NLSDM) presents with skeletal muscle myopathy and severe dilated cardiomyopathy in nearly 40% of cases. NLSDM is caused by mutations in the PNPLA2 gene, which encodes the adipose triglyceride lipase (ATGL). Here we report clinical and genetic findings of...

Descripción completa

Detalles Bibliográficos
Autores principales: Missaglia, Sara, Maggi, Lorenzo, Mora, Marina, Gibertini, Sara, Blasevich, Flavia, Agostoni, Piergiuseppe, Moro, Laura, Cassandrini, Denise, Santorelli, Filippo Maria, Gerevini, Simonetta, Tavian, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pergamon Press 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424884/
https://www.ncbi.nlm.nih.gov/pubmed/28258942
http://dx.doi.org/10.1016/j.nmd.2017.01.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424884/
https://www.ncbi.nlm.nih.gov/pubmed/28258942
http://dx.doi.org/10.1016/j.nmd.2017.01.011

Ejemplares similares